Prolonged local persistence of cisplatin-loaded gelatin microspheres and their chemoembolic anti-cancer effect in rabbits

European Journal of Radiology

Volumn 72, Issue 3, 2009, Pages 534-540

  Ohta, Shinichi ^a   Nitta, Norihisa ^a   Sonoda, Akinaga ^a   Seko, Ayumi ^a   Tanaka, Toyohiko ^a   Takahashi, Masashi ^a   Takemura, Shizuki ^a   Tabata, Yasuhiko ^b   Murata, Kiyoshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Animal experiment; Chemoembolization; Cisplatin; Drug delivery system; Microspheres

Indexed keywords

ANIMAL EXPERIMENTS; ATOMIC ABSORPTION; CIS-PLATIN; DRUG DELIVERY SYSTEM; FOUR-GROUP; GELATIN MICROSPHERES; GROUP III; HEPATIC ARTERY; HEPATOCYTES; LIVER CELLS; LIVER TUMORS; PLATINUM CONCENTRATION; RENAL ARTERIES; SIMILAR DEGREE; TUMOR GROWTH; TUMOR VOLUMES;

ANIMALS; DRUG DELIVERY; EXPERIMENTS; FLUORINE CONTAINING POLYMERS; LIVER; MICROSPHERES; ONCOLOGY; PLATINUM; TUMORS;

PLATINUM COMPOUNDS;

CISPLATIN; GELATIN; IOPAMIDOL; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC ABSORPTION; CANCER CHEMOTHERAPY; CELL DEATH; CHEMOEMBOLIZATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG INFUSION; DRUG TISSUE LEVEL; EXPERIMENTAL RABBIT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY INFARCTION; KIDNEY PARENCHYMA; LIVER CELL; LIVER INJURY; LIVER TUMOR; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; GELATIN; LIVER NEOPLASMS; METABOLIC CLEARANCE RATE; MICROSPHERES; RABBITS; TISSUE DISTRIBUTION;

EID: 70449673590     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.07.030     Document Type: Article

References (19)

1. Yamada R., Sato M., Kawabata M., Nakatsuka H., Nakamura K., and Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148 2 (1983) 397-401
2. Kudo M., and Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72 Suppl. 1 (2007) 2-15
3. Jiaqi Y., Hori S., Minamitani K., et al. A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects. Nihon Igaku Hoshasen Gakkai zasshi 56 1 (1996) 19-24
4. Brown D.B., Pilgram T.K., Darcy M.D., et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 16 12 (2005) 1661-1666
5. Furuse J., Ishii H., Satake M., et al. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma. Am J Clin Oncol 26 2 (2003) 159-164
6. Schubiger P.A., Beer H.F., Geiger L., et al. 90Y-resin particles-animal experiments on pigs with regard to the introduction of superselective embolization therapy. Int J Rad Appl Instrum B 18 3 (1991) 305-311
7. Osuga K., Khankan A.A., Hori S., et al. Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience. J Vasc Interv Radiol 13 9 Pt 1 (2002) 929-934
8. Ohta S., Nitta N., Takahashi M., Murata K., and Tabata Y. Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model. Korean J Radiol 8 5 (2007) 418-428
9. Nitta N., Ohta S., Tanaka T., et al. Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization. Eur J Radiol 67 3 (2008) 536-540
10. Nitta N., Ohta S., Tanaka T., et al. An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors. Eur J Radiol July (2008) [Epub ahead of print]
11. Varela M., Real M.I., Burrel M., et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46 3 (2007) 474-481
12. Lewis A.L., Gonzalez M.V., Leppard S.W., et al. Doxorubicin eluting beads-1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med 18 9 (2007) 1691-1699
13. Ohta S, Nitta N, Sonoda A, et al. Cisplatin-conjugated degradable gelatin microspheres: fundamental study in vitro. Br J Radiol; in press.
14. Ohta S., Nitta N., Sonoda A., et al. Cisplatin-conjugated Gelpart: initial study in vitro. Hepatol Res May (2008) [Epub ahead of print]
15. Konishi M., Tabata Y., Kariya M., et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release 103 1 (2005) 7-19
16. Konishi M., Tabata Y., Kariya M., et al. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Control Release 92 3 (2003) 301-313
17. Makuuchi M., Sukigara M., Mori T., et al. Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology 156 2 (1985) 331-334
18. Schoen F. The heart. In: Kumar V., Abbas A.K., and Fausto N. (Eds). Kumar: Robbins and Cotran: pathologic basis of disease. 7th ed. (2005), Elsevier Saunders, Philadelphia, PA 575-586
19. Xie J., Tan R.S., and Wang C.H. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro. J Biomed Mater Res A 85 4 (2008) 897-908